Llwytho...
Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis
AIMS: To develop a population pharmacokinetic model for pyrimethamine (PYR) and sulfadoxine (SDX) in children with congenital toxoplasmosis. METHODS: Children were treated with PYR (1.25 mg kg(−1)) and SDX (25 mg kg(−1)) (Fansidar®) plus folinic acid (Lederfoline® 5 mg). Plasma concentrations, avail...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Blackwell Science Inc
2004
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1884514/ https://ncbi.nlm.nih.gov/pubmed/15151519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2004.02077.x |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|